Filing Flows

Filing Flows › NRX Pharmaceuticals (NRXP) › How it makes money

How NRX Pharmaceuticals (NRXP) makes money

NRX Pharmaceuticals (NRXP) made $1.1M of revenue in the second quarter 2026 (Q2 2026). Therapy brought in $871K (79%); Procedures brought in $230K (21%).

Drawing the Sankey…

NRX Pharmaceuticals revenue by segment, Q2 2026NRX Pharmaceuticals revenue by segment, Q2 2026Therapy$871KProcedures$230K
NRX Pharmaceuticals: revenue by line, Q3 2025 to Q2 2026NRX Pharmaceuticals: revenue by line, Q3 2025 to Q2 2026TherapyProceduresOther revenuesTherapy: $871K latest$871KProcedures: $230K latest$230KOther revenues: $0 latestQ3 2025Q4 2025Q1 2026Q2 2026
Therapy went from 63% of revenue in Q3 2025 to 79% in Q2 2026, the largest shift in the mix.
NRX Pharmaceuticals revenue by quarterNRX Pharmaceuticals revenue by quarter$242KQ3 2025$1.2MQ4 2025$1.1MQ1 2026$1.1MQ2 2026

Revenue by segment, Q2 2026

SegmentRevenueShareQ/QY/Y
Therapy$871K79.1%+15%—
Procedures$230K20.9%-25%—

Where each dollar of revenue goes

LineQ2 2026% of revenue
Revenue$1.1M100.0%

Revenue, quarter by quarter

QuarterRevenueY/Y
Q2 2026$1.1M—
Q1 2026$1.1M—
Q4 2025$1.2M—
Q3 2025$242K—

From NRX Pharmaceuticals' 10-Q filed Aug 14, 2026 (on EDGAR).

Questions

How does NRX Pharmaceuticals make money?

NRX Pharmaceuticals (NRXP) made $1.1M of revenue in the second quarter 2026 (Q2 2026). Therapy brought in $871K (79%); Procedures brought in $230K (21%).

What is NRX Pharmaceuticals' biggest business?

Therapy: $871K in the second quarter 2026, 79% of revenue.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.